skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Treatment of severe psoriasis with infliximab

Review

(2947) Views  (466) Full article downloads

Authors: JA Leman, AD Burden

Published Date November 2008 Volume 2008:4(6) Pages 1165 - 1175
DOI: http://dx.doi.org/10.2147/TCRM.S3094

JA Leman, AD Burden

Alan Lyell Centre for Dermatology, Western Infirmary, Glasgow, UK

Abstract: Psoriasis is a chronic, immune mediated inflammatory disease characterized by increased cell signalling via cytokines and chemokines on a background of up-regulated gene expression. There is substantial evidence that psoriasis should be regarded as more than a cutaneous disease; major psychological morbidity and increased mortality from cardiovascular disease and cancer are increasingly recognized. Improved understanding of the genetic and immunological mechanisms underpinning psoriasis has occurred concurrently with the development of targeted biological therapies including infliximab. These newer therapeutic approaches can be very effective but their long term safety profile is not yet fully determined.

Keywords: psoriasis, pathogenesis, co-morbidities, treatment, infliximab








Readers of this article also read:

Factors affecting therapeutic compliance: A review from the patient’s perspective
Biological drugs targeting the immune response in the therapy of psoriasis
Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer
Age-related macular degeneration and the aging eye
Docetaxel in the treatment of squamous cell carcinoma of the head and neck
Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children
Computational methods for the identification of microRNA targets
Erratum - Intracellular heavy metal nanoparticle storage